Cargando…

OxLDL/β2GPI/anti-β2GPI Ab complex induces inflammatory activation via the TLR4/NF-κB pathway in HUVECs

Patients with antiphospholipid syndrome have been identified to have higher incidence rates of atherosclerosis (AS) due to the elevated levels of anti-β2-glycoprotein I (β2GPI) antibody (Ab). Our previous studies revealed that the anti-β2GPI Ab formed a stable oxidized low-density lipoprotein (oxLDL...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Guiting, Cai, Qianqian, Zhou, Hong, He, Chao, Chen, Yudan, Zhang, Peng, Wang, Ting, Xu, Liangjie, Yan, Jinchuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789093/
https://www.ncbi.nlm.nih.gov/pubmed/33355374
http://dx.doi.org/10.3892/mmr.2020.11787
_version_ 1783633165369212928
author Zhang, Guiting
Cai, Qianqian
Zhou, Hong
He, Chao
Chen, Yudan
Zhang, Peng
Wang, Ting
Xu, Liangjie
Yan, Jinchuan
author_facet Zhang, Guiting
Cai, Qianqian
Zhou, Hong
He, Chao
Chen, Yudan
Zhang, Peng
Wang, Ting
Xu, Liangjie
Yan, Jinchuan
author_sort Zhang, Guiting
collection PubMed
description Patients with antiphospholipid syndrome have been identified to have higher incidence rates of atherosclerosis (AS) due to the elevated levels of anti-β2-glycoprotein I (β2GPI) antibody (Ab). Our previous studies revealed that the anti-β2GPI Ab formed a stable oxidized low-density lipoprotein (oxLDL)/β2GPI/anti-β2GPI Ab complex, which accelerated AS development by promoting the accumulation of lipids in macrophages and vascular smooth muscle cell. However, the effects of the complex on endothelial cells, which drive the initiation and development of AS, remain unknown. Thus, the present study aimed to determine the proinflammatory roles of the oxLDL/β2GPI/anti-β2GPI Ab complex in human umbilical vein endothelial cells (HUVECs) in an attempt to determine the underlying mechanism. Reverse transcription-quantitative PCR, enzymy-linked immunosorbent assay, western blotting and immunofluorescence staining were performed to detect the expressions of inflammation related factors and adhesion molecules. Monocyte-binding assay was used to investigate the effects of oxLDL/β2GPI/anti-β2GPI Ab complex on monocyte adhesion to endothelial cells. The results demonstrated that the oxLDL/β2GPI/anti-β2GPI Ab complex upregulated the expression of Toll-like receptor (TLR)4 and the levels of NF-κB phosphorylation in HUVECs, and subsequently enhanced the expression levels of inflammatory cytokines, including TNF-α, IL-1β and IL-6, as well as those of adhesion molecules, such as intercellular adhesion molecule 1 and vascular adhesion molecule 1. In addition, the complex facilitated the recruitment of monocytes by promoting the secretion of monocyte chemotactic protein 1 in HUVECs. Notably, the described effects of the oxLDL/β2GPI/anti-β2GPI Ab complex in HUVECs were abolished by either TLR4 or NF-κB blockade. In conclusion, these findings suggested that the oxLDL/β2GPI/anti-β2GPI Ab complex may induce a hyper-inflammatory state in endothelial cells by promoting the secretion of proinflammatory cytokines and monocyte recruitment, which was discovered to be largely dependent on the TLR4/NK-κB signaling pathway.
format Online
Article
Text
id pubmed-7789093
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-77890932021-01-11 OxLDL/β2GPI/anti-β2GPI Ab complex induces inflammatory activation via the TLR4/NF-κB pathway in HUVECs Zhang, Guiting Cai, Qianqian Zhou, Hong He, Chao Chen, Yudan Zhang, Peng Wang, Ting Xu, Liangjie Yan, Jinchuan Mol Med Rep Articles Patients with antiphospholipid syndrome have been identified to have higher incidence rates of atherosclerosis (AS) due to the elevated levels of anti-β2-glycoprotein I (β2GPI) antibody (Ab). Our previous studies revealed that the anti-β2GPI Ab formed a stable oxidized low-density lipoprotein (oxLDL)/β2GPI/anti-β2GPI Ab complex, which accelerated AS development by promoting the accumulation of lipids in macrophages and vascular smooth muscle cell. However, the effects of the complex on endothelial cells, which drive the initiation and development of AS, remain unknown. Thus, the present study aimed to determine the proinflammatory roles of the oxLDL/β2GPI/anti-β2GPI Ab complex in human umbilical vein endothelial cells (HUVECs) in an attempt to determine the underlying mechanism. Reverse transcription-quantitative PCR, enzymy-linked immunosorbent assay, western blotting and immunofluorescence staining were performed to detect the expressions of inflammation related factors and adhesion molecules. Monocyte-binding assay was used to investigate the effects of oxLDL/β2GPI/anti-β2GPI Ab complex on monocyte adhesion to endothelial cells. The results demonstrated that the oxLDL/β2GPI/anti-β2GPI Ab complex upregulated the expression of Toll-like receptor (TLR)4 and the levels of NF-κB phosphorylation in HUVECs, and subsequently enhanced the expression levels of inflammatory cytokines, including TNF-α, IL-1β and IL-6, as well as those of adhesion molecules, such as intercellular adhesion molecule 1 and vascular adhesion molecule 1. In addition, the complex facilitated the recruitment of monocytes by promoting the secretion of monocyte chemotactic protein 1 in HUVECs. Notably, the described effects of the oxLDL/β2GPI/anti-β2GPI Ab complex in HUVECs were abolished by either TLR4 or NF-κB blockade. In conclusion, these findings suggested that the oxLDL/β2GPI/anti-β2GPI Ab complex may induce a hyper-inflammatory state in endothelial cells by promoting the secretion of proinflammatory cytokines and monocyte recruitment, which was discovered to be largely dependent on the TLR4/NK-κB signaling pathway. D.A. Spandidos 2021-02 2020-12-17 /pmc/articles/PMC7789093/ /pubmed/33355374 http://dx.doi.org/10.3892/mmr.2020.11787 Text en Copyright: © Zhang et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Zhang, Guiting
Cai, Qianqian
Zhou, Hong
He, Chao
Chen, Yudan
Zhang, Peng
Wang, Ting
Xu, Liangjie
Yan, Jinchuan
OxLDL/β2GPI/anti-β2GPI Ab complex induces inflammatory activation via the TLR4/NF-κB pathway in HUVECs
title OxLDL/β2GPI/anti-β2GPI Ab complex induces inflammatory activation via the TLR4/NF-κB pathway in HUVECs
title_full OxLDL/β2GPI/anti-β2GPI Ab complex induces inflammatory activation via the TLR4/NF-κB pathway in HUVECs
title_fullStr OxLDL/β2GPI/anti-β2GPI Ab complex induces inflammatory activation via the TLR4/NF-κB pathway in HUVECs
title_full_unstemmed OxLDL/β2GPI/anti-β2GPI Ab complex induces inflammatory activation via the TLR4/NF-κB pathway in HUVECs
title_short OxLDL/β2GPI/anti-β2GPI Ab complex induces inflammatory activation via the TLR4/NF-κB pathway in HUVECs
title_sort oxldl/β2gpi/anti-β2gpi ab complex induces inflammatory activation via the tlr4/nf-κb pathway in huvecs
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789093/
https://www.ncbi.nlm.nih.gov/pubmed/33355374
http://dx.doi.org/10.3892/mmr.2020.11787
work_keys_str_mv AT zhangguiting oxldlb2gpiantib2gpiabcomplexinducesinflammatoryactivationviathetlr4nfkbpathwayinhuvecs
AT caiqianqian oxldlb2gpiantib2gpiabcomplexinducesinflammatoryactivationviathetlr4nfkbpathwayinhuvecs
AT zhouhong oxldlb2gpiantib2gpiabcomplexinducesinflammatoryactivationviathetlr4nfkbpathwayinhuvecs
AT hechao oxldlb2gpiantib2gpiabcomplexinducesinflammatoryactivationviathetlr4nfkbpathwayinhuvecs
AT chenyudan oxldlb2gpiantib2gpiabcomplexinducesinflammatoryactivationviathetlr4nfkbpathwayinhuvecs
AT zhangpeng oxldlb2gpiantib2gpiabcomplexinducesinflammatoryactivationviathetlr4nfkbpathwayinhuvecs
AT wangting oxldlb2gpiantib2gpiabcomplexinducesinflammatoryactivationviathetlr4nfkbpathwayinhuvecs
AT xuliangjie oxldlb2gpiantib2gpiabcomplexinducesinflammatoryactivationviathetlr4nfkbpathwayinhuvecs
AT yanjinchuan oxldlb2gpiantib2gpiabcomplexinducesinflammatoryactivationviathetlr4nfkbpathwayinhuvecs